|Articles|October 15, 2001
- BioPharm International-10-01-2001
- Volume 14
- Issue 10
Outsourcing Outlook
Author(s)Jim Miller
by Jim Miller
Advertisement
Articles in this issue
over 24 years ago
Statistical Tools for Setting In-Process Acceptance Criteriaover 24 years ago
Managing Your Career: Recruiter-Proof Your Organizationover 24 years ago
Inside Washington: Crisis and Costs Grip Biotech IndustryNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy
2
WHO Finalizes United States’ Withdrawal from Organization: Report
3
Green Chemistry’s Role in Advancing US Chemical Innovation
4
Industry Outlook 2026: Biopharma Industry Confronts Skills Shortage with Strategic Automation (Part 2)
5
